Sensus Healthcare (SRTS) CEO buys 20,000 shares on market
Rhea-AI Filing Summary
Sensus Healthcare, Inc. (SRTS) reported that its Chief Executive Officer and director, Joseph C. Sardano, purchased 20,000 shares of common stock on 2026-08-20 in an open-market or private transaction at $3.0243 per share. Following this transaction, he directly owns 1,220,293 shares of SRTS common stock.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Buyer: 20,000 shares
Net Buy
1 txn
Insider
Sardano Joseph C
Role
CHIEF EXECUTIVE OFFICER
Bought
20,000 shs ($60K)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Purchase | Common Stock | 20,000 | $3.0243 | $60K |
Holdings After Transaction:
Common Stock — 1,220,293 shares (Direct)
Key Figures
Shares purchased: 20,000 shares of Common Stock
Purchase price per share: $3.0243 per share
Shares owned after transaction: 1,220,293 shares
+1 more
4 metrics
Shares purchased
20,000 shares of Common Stock
Purchase on 2026-08-20 reported on Form 4
Purchase price per share
$3.0243 per share
Open-market or private transaction on 2026-08-20
Shares owned after transaction
1,220,293 shares
Direct ownership by Joseph C. Sardano following the trade
Net buy shares
20,000 shares
Net effect of reported transactions in this Form 4
Key Terms
Form 4, Common Stock, Rule 10b5-1
3 terms
Form 4 regulatory
"reported on Form 4"
Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.
Common Stock financial
"security_title": "Common Stock""
Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.
Rule 10b5-1 regulatory
"indicates the Rule 10b5-1 checkbox is not affirmed"
Rule 10b5-1 is a regulation that allows company insiders to buy or sell their shares at predetermined times, even if they have access to non-public information. It acts like setting a schedule in advance for transactions, helping prevent accusations of unfair trading. This rule provides a way for insiders to plan trades transparently, giving investors confidence that these transactions are not based on hidden information.
FAQ
What insider transaction did Sensus Healthcare (SRTS) report for Joseph C. Sardano?
Sensus Healthcare reported that CEO and director Joseph C. Sardano purchased 20,000 shares of SRTS common stock on 2026-08-20 in an open-market or private transaction at $3.0243 per share, bringing his direct holdings to 1,220,293 shares.
Was the recent SRTS insider trade by Joseph C. Sardano a purchase or a sale?
The reported insider trade by Joseph C. Sardano was a purchase. He acquired 20,000 shares of Sensus Healthcare common stock on 2026-08-20 at $3.0243 per share, increasing his direct ownership to 1,220,293 shares.
Was the SRTS CEO’s Form 4 transaction under a Rule 10b5-1 trading plan?
The filing indicates the Rule 10b5-1 checkbox is not affirmed (set to false), meaning the reported 20,000-share purchase by CEO Joseph C. Sardano on 2026-08-20 was not stated to be pursuant to a Rule 10b5-1 trading plan.
AI-generated analysis. How Rhea-AI works. Not financial advice.
